Create an account to read this article
You need to create an account to read this article.
Create Account Sign in
Cardiology and CTVS
Medicine

Evolocumab Reduces Major Adverse Cardiovascular Events In Patients With And Without Multivessel Disease: FOURIER
- byDoctor News Daily Team
- 18 February, 2025
- 0 Comments
- 0 Mins


Recent News

Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!